Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000551
Filing Date
2017-08-08
Accepted
2017-08-08 16:03:14
Documents
1
Period of Report
2017-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8006
  Complete submission text file 0000904454-17-000551.txt   9494
Mailing Address 5880 PACIFIC CENTER BLVD SAN DIEGO CA 92121-4204
Business Address
BLAIR JAMES C (Reporting) CIK: 0001024000 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 171014658
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations